SCOPUS 정보 검색 플랫폼

Circulation

Volumn 135, Issue 19, 2017, Pages 1769-1771

Cardiovascular outcome trials in patients with advanced kidney disease

(2) Zannad, Faiez a,b Rossignol, Patrick a,b,c

a UNIVERSITÉ DE LORRAINE (France)

b INI CRCT (France)

c Association Lorraine Pour le Traitement de l'Insuffisance Ré Nale (France)

Author keywords

cardiovascular diseases; cardiovascular outcomes; clinical trial; kidney; renal insufficiency

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; HUMAN; KIDNEY DISEASE; PATIENT DECISION MAKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; CLINICAL DECISION MAKING; CLINICAL TRIAL (TOPIC); DISEASE EXACERBATION; FRANCE; OUTCOME ASSESSMENT; PATIENT SELECTION; RISK FACTOR;

CARDIOVASCULAR DISEASES; CLINICAL DECISION-MAKING; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; FRANCE; HUMANS; KIDNEY DISEASES; PATIENT OUTCOME ASSESSMENT; PATIENT SELECTION; RISK FACTORS;

EID: 85019849469 PISSN: 00097322 EISSN: 15244539 Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.117.027338 Document Type: Article

Times cited : (35)

References (5)

1
- 33845235462
- The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease
- Charytan D, Kuntz RE, The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int 2006 70 2021 2030. doi: 10.1038/sj.ki.5001934
- (2006) Kidney Int , vol.70 , pp. 2021-2030
- Charytan, D.¹ Kuntz, R.E.²

2
- 33748895492
- Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease
- Coca SG, Krumholz HM, Garg AX, Parikh CR, Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 2006 296 1377 1384. doi: 10.1001/jama.296.11.1377
- (2006) JAMA , vol.296 , pp. 1377-1384
- Coca, S.G.¹ Krumholz, H.M.² Garg, A.X.³ Parikh, C.R.⁴

3
- 84954466026
- Representation of patients with kidney disease in trials of cardiovascular interventions: An updated systematic review
- Konstantinidis I, Nadkarni GN, Yacoub R, Saha A, Simoes P, Parikh CR, Coca SG, Representation of patients with kidney disease in trials of cardiovascular interventions: an updated systematic review. JAMA Intern Med 2016 176 121 124. doi: 10.1001/jamainternmed.2015.6102
- (2016) JAMA Intern Med , vol.176 , pp. 121-124
- Konstantinidis, I.¹ Nadkarni, G.N.² Yacoub, R.³ Saha, A.⁴ Simoes, P.⁵ Parikh, C.R.⁶ Coca, S.G.⁷

4
- 84979729781
- Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: A meta-analysis of individual participant data from 28 randomised trials
- Cholesterol Treatment Trialists' (CTT) Collaboration
- Herrington WG, Emberson J, Mihaylova B, Blackwell L, Reith C, Solbu MD, Mark PB, Fellström B, Jardine AG, Wanner C, Holdaas H, Fulcher J, Haynes R, Landray MJ, Keech A, Simes J, Collins R, Baigent C, Cholesterol Treatment Trialists' (CTT) Collaboration Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials. Lancet Diabetes Endocrinol 2016 4 829 839. doi: 10.1016/S2213-8587(16)30156-5
- (2016) Lancet Diabetes Endocrinol , vol.4 , pp. 829-839
- Herrington, W.G.¹ Emberson, J.² Mihaylova, B.³ Blackwell, L.⁴ Reith, C.⁵ Solbu, M.D.⁶ Mark, P.B.⁷ Fellström, B.⁸ Jardine, A.G.⁹ Wanner, C.¹⁰ Holdaas, H.¹¹ Fulcher, J.¹² Haynes, R.¹³ Landray, M.J.¹⁴ Keech, A.¹⁵ Simes, J.¹⁶ Collins, R.¹⁷ Baigent, C.¹⁸

5
- 84992618639
- Roadmap for cardiovascular prevention trials in chronic kidney disease
- Rossignol P, Pitt B, Thompson A, Zannad F, Roadmap for cardiovascular prevention trials in chronic kidney disease. Lancet 2016 388 1964 1966. doi: 10.1016/S0140-6736(16)31331-9
- (2016) Lancet , vol.388 , pp. 1964-1966
- Rossignol, P.¹ Pitt, B.² Thompson, A.³ Zannad, F.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.